Back to Journals » OncoTargets and Therapy » Volume 11

Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancer

Total article views   HTML views PDF downloads Totals
9,584 Dovepress* 8,563+ 909 9,472
PubMed Central* 1,021 361 1,382
Totals 9,584 1,270 10,854
*Since 15 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 1 0 5

View citations on PubMed Central and Google Scholar